"10.1371_journal.pone.0124590","plos one","2015-04-21T00:00:00Z","Wiebke Sondermann; Klaus G Griewank; Bastian Schilling; Elisabeth Livingstone; Julia C Leyh; Natalia Rompoti; Ioana Cosgarea; Tobias Schimming; Dirk Schadendorf; Lisa Zimmer; Uwe Hillen","Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany","Conceived and designed the experiments: WS KGG BS LZ UH. Performed the experiments: WS BS JCL NR IC TS. Analyzed the data: WS KGG BS EL DS LZ UH. Contributed reagents/materials/analysis tools: WS KGG BS EL. Wrote the paper: WS KGG BS EL JCL NR IC TS DS LZ UH.","Wiebke Sondermann has received honoraria from Roche and travel support from Bristol-Myers Squibb. Bastian Schilling has received honoraria from Roche and travel support as well research funding from Bristol-Myers Squibb. Elisabeth Livingstone has received honoraria from Roche, Bristol-Myers Squibb, Amgen, Boehringer Ingelheim, Merck Sharp & Dohme, and Merck, and travel support from Bristol-Myers Squibb. Lisa Zimmer has received honoraria from Roche, Bristol-Myers Squibb, Boehringer Ingelheim and Amgen, and travel support from Merck Sharp & Dohme and Bristol-Myers Squibb. Uwe Hillen has received honoraria from Roche. Dirk Schadendorf is on the advisory board or has received honoraria from Roche, Genentech, Novartis, Amgen, GlaxoSmithKline, Bristol-Myers Squibb, Boehringer Ingelheim, and Merck Sharp & Dohme. The remaining authors have declared no conflicts of interest. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","04","Wiebke Sondermann","WS",11,TRUE,5,6,7,11,TRUE,TRUE,FALSE,0,NA,FALSE
